ARTICLE
9 October 2025

OECD Publishes Guidance Document On Assessing The Apparent Accumulation Potential Of Nanomaterials

BC
Bergeson & Campbell

Contributor

Bergeson & Campbell, P.C. is a Washington D.C. law firm focusing on chemical product approval and regulation, product defense, and associated business issues. The Acta Group, B&C's scientific and regulatory consulting affiliate provides strategic, comprehensive support for global chemical registration, regulation, and sustained compliance. Together, we help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products globally.
The Organisation for Economic Co-operation and Development (OECD) has published a September 2025 document entitled Guidance Document on Assessing the Apparent Accumulation Potential of Nanomaterials.
United States Environment
Lynn L. Bergeson Esq.’s articles from Bergeson & Campbell are most popular:
  • within Environment topic(s)
  • in United States
Bergeson & Campbell are most popular:
  • within Real Estate and Construction, Energy and Natural Resources and Tax topic(s)

The Organisation for Economic Co-operation and Development (OECD) has published a September 2025 document entitled Guidance Document on Assessing the Apparent Accumulation Potential of Nanomaterials. The document is intended to provide specific advice on how to conduct bioaccumulation tests in fish with nanomaterials following Test Guideline (TG) 305 (OECD 2012), once it has been decided that such a fish test is needed. The purpose is to offer guidance on the critical points indicated in the Introduction section to generate harmonized results that can inform reliably on the accumulation potential of nanomaterials. Considerations about the most appropriate testing regime (i.e., aqueous versus dietary), guidance for the preparation of stable and reproducible suspensions, indications on the appropriateness of the approaches proposed to derive the bioconcentration factor (BCF) and the biomagnification factor (BMF), the validity of BMF to assess the bioaccumulation of nanomaterials, and the availability of methods to determine tissue/fish concentrations are included in the document.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More